DataSheet1_Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction.PDF by Juan Martínez (4474276)

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

Subjects:

Change in laryngeal measures with disease duration and UPDRS part III scores. by Andrew Ma (4532494)

Subjects:

Force and displacement in sandstone variable lower limit step loading. by Tong Zhuang (17847113)

Subjects:

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Performances of the three machine learning models based on ten-fold cross-validation and walk-forward validation: Multiple linear regression (MLR), random forest (RF), and a deep n... by Yingjie Hu (1579000)

Subjects:

Model fit for Mixed-Effects Multi-linear Regressions with PSS as a continuous outcome measure. by Laura S. P. Bloomfield (3820531)

Subjects:

Differences in PAB of young children with increasing age [N (%)]. by Xin Xiong (113595)

Subjects:

The schematic diagram of the change law of the internal pores of the sample during the freeze-thaw cycle. by Hongqi Wang (2208238)

Subjects:

Participants inclination toward gambling exhibited a significant increase as the reward magnitude and reward probability increased. by Yasuhiro Mochizuki (3308349)

Pathological changes in lung tissue of mice exposed to continuous inhalation of CS. by Yue He (385239)

Subjects:

Differences in PH levels of young children with increasing age [N (%)]. by Xin Xiong (113595)

Subjects:

Succinate and Sucnr1 levels were significantly increased. by Jiaqi Wang (369548)

Model fit for Mixed-Effects Multi-linear Regressions with PSS-Moderate (PSS> = 14) as a binary outcome measure. by Laura S. P. Bloomfield (3820531)

Subjects:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

Subjects:

Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects:

Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

Subjects: